DNLI
DENALI THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
DENALI THERAPEUTICS INC (DNLI) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$127.78M; the largest are Baker Bros. Advisors, Izzy Englander, Ken Griffin. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 2 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Quiet
Common-stock holders42 also report options
Congress trades0
Price$20.81vs quarter-end-19.09%
Sectors0
This quarter's moves
Top holderBaker Bros. AdvisorsNew1
Added0
Trimmed / sold2
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $96.05M0.5% of portfolio3,734,3362026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $96.05M | 0.5% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $11.72M— of portfolio455,8002026 Q2
Value $1.99M— of portfolio77,3002026 Q2
Value $596.7K— of portfolio23,2002026 Q2
Value $596.7K— of portfolio23,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $11.72M | — | — |
| Ken GriffinCALL | $1.99M | — | — |
| Steven CohenCALL | $596.7K | — | — |
| Steven CohenPUT | $596.7K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.